Search for Clinical Trial Results
Leukemia, Myelomonocytic, Acute - 25 Studies Found
Status | Study |
Active, not recruiting |
Study Name: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia Condition:
|
Active, not recruiting |
Study Name: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia Condition:
|
Active, not recruiting |
Study Name: Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Condition:
|